Alnylam Pharmaceuticals
ALNY
ALNY
355 hedge funds and large institutions have $15.8B invested in Alnylam Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 124 increasing their positions, 129 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
355
Holders Change
-18
Holders Change %
-4.83%
% of All Funds
7.18%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.14%
New
32
Increased
124
Reduced
129
Closed
49
Calls
$121M
Puts
$131M
Net Calls
-$9.8M
Net Calls Change
-$52.2M
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$2.4B |
| 2 |
Goldman Sachs
New York
|
$85.5M |
| 3 |
SPC
Slate Path Capital
New York
|
$31M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$1.53B |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
$1.48B |
